Wordt geladen...
How to design preclinical studies in nanomedicine and cell therapy to maximize the prospects of clinical translation
The clinical translation of promising products, technologies and interventions from the disciplines of nanomedicine and cell therapy has been slow and inefficient. In part, translation has been hampered by suboptimal research practices that propagate biases and hinder reproducibility. These include...
Bewaard in:
| Gepubliceerd in: | Nat Biomed Eng |
|---|---|
| Hoofdauteurs: | , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2018
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6436641/ https://ncbi.nlm.nih.gov/pubmed/30931172 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41551-018-0314-y |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|